The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Hecht Peter M since 2012.
This trader's CIK number is 1478485.
At the time of last reporting, Hecht Peter M was the Chief Executive Officer of Cyclerion Therapeutics, Inc.. (stock ticker symbol CYCN).
Also see all insider trading activities at Cyclerion Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | CYCN | 1,823,171 | $5,127,799 | 0 | $0 | 0 | $0 |
| 2019 | CYCN | 0 | $0 | 0 | $0 | 2,000 | $12,080 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | IRWD | 0 | $0 | 89,551 | $1,122,208 | 110,000 | $537,899 |
| 2017 | IRWD | 0 | $0 | 179,392 | $2,748,531 | 205,987 | $720,400 |
| 2016 | IRWD | 0 | $0 | 120,000 | $1,286,399 | 300,790 | $469,232 |
| 2015 | IRWD | 0 | $0 | 336,860 | $4,944,260 | 778,223 | $1,057,560 |
| 2014 | IRWD | 0 | $0 | 0 | $0 | 225,000 | $135,000 |
| 2013 | IRWD | 0 | $0 | 0 | $0 | 100,000 | $60,000 |
| 2012 | IRWD | 50,000 | $582,500 | 0 | $0 | 150,000 | $61,499 |
1. Cyclerion Therapeutics, Inc. (CYCN)
2. Ironwood Pharmaceuticals Inc (IRWD)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-03 | CYCN | Buy | 823,170 | 3.28 | 2,699,997 |
| 2021-05-06 | CYCN | Buy | 302,000 | 2.43 | 733,860 |
| 2021-05-05 | CYCN | Buy | 398,001 | 2.53 | 1,006,942 |
| 2021-05-04 | CYCN | Buy | 300,000 | 2.29 | 687,000 |
| 2019-07-10 | CYCN | Option Ex | 2,000 | 6.04 | 12,080 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-25 | IRWD | Sale | 29,551 | 12.23 | 361,408 |
| 2019-01-24 | IRWD | Sale | 30,000 | 12.70 | 381,000 |
| 2019-01-25 | IRWD | Option Ex | 50,000 | 4.89 | 244,499 |
| 2019-01-23 | IRWD | Sale | 30,000 | 12.66 | 379,800 |
| 2019-01-24 | IRWD | Option Ex | 30,000 | 4.89 | 146,700 |
| 2019-01-23 | IRWD | Option Ex | 30,000 | 4.89 | 146,700 |
| 2017-12-07 | IRWD | Sale | 57,405 | 15.00 | 861,075 |
| 2017-12-06 | IRWD | Sale | 56,000 | 15.24 | 853,440 |
| 2017-12-07 | IRWD | Option Ex | 57,405 | 3.76 | 215,842 |
| 2017-12-06 | IRWD | Option Ex | 82,595 | 3.76 | 310,557 |
| 2017-01-11 | IRWD | Option Ex | 32,993 | 2.94 | 96,999 |
| 2017-01-12 | IRWD | Sale | 32,994 | 15.50 | 511,407 |
| 2017-01-12 | IRWD | Option Ex | 32,994 | 2.94 | 97,002 |
| 2017-01-11 | IRWD | Sale | 32,993 | 15.84 | 522,609 |
| 2016-03-09 | IRWD | Option Ex | 220,790 | 1.56 | 344,432 |
| 2016-03-10 | IRWD | Option Ex | 40,000 | 1.56 | 62,400 |
| 2016-03-11 | IRWD | Option Ex | 40,000 | 1.56 | 62,400 |
| 2016-03-09 | IRWD | Sale | 40,000 | 10.87 | 434,799 |
| 2016-03-10 | IRWD | Sale | 40,000 | 10.63 | 425,200 |
| 2016-03-11 | IRWD | Sale | 40,000 | 10.66 | 426,400 |
| 2015-12-15 | IRWD | Sale | 73,418 | 11.07 | 812,737 |
| 2015-12-11 | IRWD | Option Ex | 250,000 | 1.56 | 390,000 |
| 2015-10-28 | IRWD | Option Ex | 98,115 | 2.02 | 198,192 |
| 2015-03-17 | IRWD | Sale | 125,000 | 15.69 | 1,961,250 |
| 2015-03-16 | IRWD | Sale | 75,000 | 15.60 | 1,170,000 |
| 2015-03-17 | IRWD | Option Ex | 125,000 | 1.56 | 195,000 |
| 2015-03-16 | IRWD | Option Ex | 75,000 | 1.56 | 117,000 |
| 2015-02-27 | IRWD | Option Ex | 210,000 | .60 | 126,000 |
| 2015-03-03 | IRWD | Sale | 6,200 | 15.71 | 97,402 |
| 2015-03-02 | IRWD | Sale | 13,908 | 16.00 | 222,528 |
| 2015-03-03 | IRWD | Option Ex | 6,200 | 1.56 | 9,672 |
| 2015-03-02 | IRWD | Option Ex | 13,908 | 1.56 | 21,696 |
| 2015-02-27 | IRWD | Sale | 43,334 | 15.70 | 680,343 |
| 2014-02-20 | IRWD | Option Ex | 225,000 | .60 | 135,000 |
| 2013-07-08 | IRWD | Option Ex | 100,000 | .60 | 60,000 |
| 2012-11-05 | IRWD | Buy | 50,000 | 11.65 | 582,500 |
| 2012-04-05 | IRWD | Option Ex | 150,000 | .41 | 61,499 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Hecht Peter M (Chief Executive Officer of Cyclerion Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.